How Cepheid's GeneXpert® System Makes Effective Patient Management Easier – in Any Setting
Catawba Valley Medical Center Leverages the GeneXpert® System
Catawba Valley Medical Center leverages Cepheid’s GeneXpert® System to improve patient care and prevent infections.
How Cepheid's GeneXpert® System Makes Effective Patient Management Easier – in Any Setting
Catawba Valley Medical Center Leverages the GeneXpert® System
Catawba Valley Medical Center leverages Cepheid’s GeneXpert® System to improve patient care and prevent infections.
Bringing Molecular Testing Closer to the Patient
PCR is Better than RIDT: IDSA Says So- Laboratory Perspective (Part 1 of a 2-part series)
Ten years after the 2009 H1N1 outbreak occurred, the IDSA updated the guidelines for the management of influenza. Learn about the new recommendations for diagnostic and treatment protocols. Hear firsthand examples from the laboratory perspective. Learn how this updated approach can streamline laboratory workflows and improve patient care.
This is the first segment of a two-part series. The second webinar explores the IDSA guidelines from a clinician's perspective.
Getting It Fast vs. Getting It Right- Clinician Perspective (Part 2 of a 2-part series)
Ten years after the 2009 H1N1 outbreak occurred, the IDSA updated the guidelines for the management of influenza. Learn about the new recommendations for diagnostic and treatment protocols. Hear firsthand examples from the laboratory perspective. Learn how this updated approach can streamline laboratory workflows and improve patient care.
Chlamydia and Gonorrhea testing in the ED and the Need for Evidence Based Medicine
In this webinar, Dr. Larissa May discusses the diagnosis of sexually transmitted infections in the Emergency Department, the need for evidence-based medicine, and how same-visit treatment and management can be facilitated with on-demand testing for CT/NG.
Acute Pharyngitis Visits in the ED: What’s the Big Deal?
Acute pharyngitis is a frequent complaint seen in the Emergency Department, and group A Streptococcus is the most common bacterial etiology of pediatric pharyngitis. Globally, 616 million people are diagnosed annually with group A Streptococcus (GAS) pharyngitis. Of these, 18.1 million cases develop severe GAS disease, and 517,000 people die every year due to GAS disease.
Understand why the status quo of testing has led to missing GAS cases and overuse of antibiotics for treatment. Learn how new advances in rapid molecular testing can improve your test results and aid in effective management of your patients.